Childhood infection and adult schizophrenia: a meta-analysis of population-based studies.

PubWeight™: 1.46‹?› | Rank: Top 5%

🔗 View Article (PMC 3485564)

Published in Schizophr Res on June 15, 2012

Authors

Golam M Khandaker1, Jorge Zimbron, Christina Dalman, Glyn Lewis, Peter B Jones

Author Affiliations

1: Department of Psychiatry, University of Cambridge, Cambridge, UK. gmk24@medschl.cam.ac.uk

Articles citing this

Schizophrenia. Lancet (2016) 1.83

Association of serum interleukin 6 and C-reactive protein in childhood with depression and psychosis in young adult life: a population-based longitudinal study. JAMA Psychiatry (2014) 1.29

Inflammation and immunity in schizophrenia: implications for pathophysiology and treatment. Lancet Psychiatry (2015) 1.29

Inflammation and the two-hit hypothesis of schizophrenia. Neurosci Biobehav Rev (2013) 0.98

A population-based study of atopic disorders and inflammatory markers in childhood before psychotic experiences in adolescence. Schizophr Res (2013) 0.89

DISC1 mouse models as a tool to decipher gene-environment interactions in psychiatric disorders. Front Behav Neurosci (2013) 0.88

Is there a role for immune-to-brain communication in schizophrenia? Psychopharmacology (Berl) (2015) 0.87

Childhood Epstein-Barr Virus infection and subsequent risk of psychotic experiences in adolescence: a population-based prospective serological study. Schizophr Res (2014) 0.87

Hospital contacts with infection and risk of schizophrenia: a population-based cohort study with linkage of Danish national registers. Schizophr Bull (2013) 0.87

Hospital admission with infection during childhood and risk for psychotic illness--a population-based cohort study. Schizophr Bull (2013) 0.85

Dysconnectivity in the frontoparietal attention network in schizophrenia. Front Psychiatry (2013) 0.81

Associations Between Maternal Infection During Pregnancy, Childhood Infections, and the Risk of Subsequent Psychotic Disorder-A Swedish Cohort Study of Nearly 2 Million Individuals. Schizophr Bull (2015) 0.79

Genome-Wide Association Studies Suggest Limited Immune Gene Enrichment in Schizophrenia Compared to 5 Autoimmune Diseases. Schizophr Bull (2016) 0.79

Shared Immune and Repair Markers During Experimental Toxoplasma Chronic Brain Infection and Schizophrenia. Schizophr Bull (2015) 0.79

Inflammation and the neural diathesis-stress hypothesis of schizophrenia: a reconceptualization. Transl Psychiatry (2017) 0.78

Candida albicans exposures, sex specificity and cognitive deficits in schizophrenia and bipolar disorder. NPJ Schizophr (2016) 0.78

Expression of immune genes on chromosome 6p21.3-22.1 in schizophrenia. Brain Behav Immun (2013) 0.78

A population-based prospective birth cohort study of childhood neurocognitive and psychological functioning in healthy survivors of early life meningitis. Ann Epidemiol (2014) 0.78

Therapeutic Targets for Neurodevelopmental Disorders Emerging from Animal Models with Perinatal Immune Activation. Int J Mol Sci (2015) 0.77

Somatic diseases and conditions before the first diagnosis of schizophrenia: a nationwide population-based cohort study in more than 900 000 individuals. Schizophr Bull (2014) 0.76

Childhood interleukin-6, C-reactive protein and atopic disorders as risk factors for hypomanic symptoms in young adulthood: a longitudinal birth cohort study. Psychol Med (2016) 0.75

The association between antibodies to neurotropic pathogens and schizophrenia: a case-control study. NPJ Schizophr (2015) 0.75

Serum C-reactive protein in adolescence and risk of schizophrenia in adulthood: A prospective birth cohort study. Brain Behav Immun (2016) 0.75

Gestational influenza and risk of hypomania in young adulthood: prospective birth cohort study. J Affect Disord (2016) 0.75

"Psychosis and Escherichia coli infection: a forgotten issue": our observation. Indian J Psychol Med (2013) 0.75

Individuals hospitalized with acute mania have increased exposure to antimicrobial medications. Bipolar Disord (2016) 0.75

Improving outcomes of first-episode psychosis: an overview. World Psychiatry (2017) 0.75

Genetic insights into the neurodevelopmental origins of schizophrenia. Nat Rev Neurosci (2017) 0.75

Articles cited by this

Measuring inconsistency in meta-analyses. BMJ (2003) 128.20

From inflammation to sickness and depression: when the immune system subjugates the brain. Nat Rev Neurosci (2008) 15.90

Common variants conferring risk of schizophrenia. Nature (2009) 10.37

Implications of normal brain development for the pathogenesis of schizophrenia. Arch Gen Psychiatry (1987) 8.81

Prenatal infection and schizophrenia: a review of epidemiologic and translational studies. Am J Psychiatry (2010) 5.27

Cytokine-associated emotional and cognitive disturbances in humans. Arch Gen Psychiatry (2001) 4.70

Child development risk factors for adult schizophrenia in the British 1946 birth cohort. Lancet (1994) 4.28

Obstetric complications and schizophrenia: historical and meta-analytic review. Am J Psychiatry (2002) 4.03

Is schizophrenia a neurodevelopmental disorder? Br Med J (Clin Res Ed) (1987) 4.02

Evidence for early-childhood, pan-developmental impairment specific to schizophreniform disorder: results from a longitudinal birth cohort. Arch Gen Psychiatry (2002) 3.59

Inflammatory cytokine alterations in schizophrenia: a systematic quantitative review. Biol Psychiatry (2007) 3.22

Adult schizophrenia following prenatal exposure to an influenza epidemic. Arch Gen Psychiatry (1988) 2.62

Incidence of schizophrenia and other psychoses in England, 1950-2009: a systematic review and meta-analyses. PLoS One (2012) 2.33

Elevated maternal interleukin-8 levels and risk of schizophrenia in adult offspring. Am J Psychiatry (2004) 2.23

A quantitative meta-analysis of population-based studies of premorbid intelligence and schizophrenia. Schizophr Res (2011) 2.09

Ontogeny of the human central nervous system: what is happening when? Early Hum Dev (2005) 1.85

Childhood cognitive functioning in schizophrenia patients and their unaffected siblings: a prospective cohort study. Schizophr Bull (2000) 1.78

Maternal cytokine levels during pregnancy and adult psychosis. Brain Behav Immun (2001) 1.74

A.E. Bennett Research Award. Prenatal rubella, premorbid abnormalities, and adult schizophrenia. Biol Psychiatry (2001) 1.66

Neurologic complications of influenza A(H1N1)pdm09: surveillance in 6 pediatric hospitals. Neurology (2012) 1.65

Adult psychosis, common childhood infections and neurological soft signs in a national birth cohort. Br J Psychiatry (2002) 1.56

Association between central nervous system infections during childhood and adult onset schizophrenia and other psychoses: a 28-year follow-up. Int J Epidemiol (1997) 1.47

Neural development, cell-cell signaling, and the "two-hit" hypothesis of schizophrenia. Schizophr Bull (2001) 1.34

Genetic and non-genetic vulnerability factors in schizophrenia: the basis of the "two hit hypothesis". J Psychiatr Res (2000) 1.34

Prenatal maternal infection, neurodevelopment and adult schizophrenia: a systematic review of population-based studies. Psychol Med (2012) 1.34

The Stockholm non-affective psychoses study (snaps): the importance of including out-patient data in incidence studies. Acta Psychiatr Scand (2009) 1.30

Infections in the CNS during childhood and the risk of subsequent psychotic illness: a cohort study of more than one million Swedish subjects. Am J Psychiatry (2007) 1.23

Childhood central nervous system infections and risk for schizophrenia. Eur Arch Psychiatry Clin Neurosci (2004) 1.07

Childhood central nervous system viral infections and adult schizophrenia. Am J Psychiatry (2003) 0.92

Does maternal body mass index during pregnancy influence risk of schizophrenia in the adult offspring? Obes Rev (2011) 0.90

Long-term outcomes of pneumococcal meningitis in childhood and adolescence. Eur J Pediatr (2011) 0.87

Characterization of three co-circulating genotypes of the small hydrophobic protein gene of mumps virus. J Gen Virol (1998) 0.86

Are common childhood or adolescent infections risk factors for schizophrenia and other psychotic disorders? Med J Aust (2009) 0.85

Cognitive and functional impairment after severe sepsis. JAMA (2011) 0.85

Coxsackie group B virus infection and acute diarrhoea occurring among children in Costa Rica. Arch Dis Child (1966) 0.82

Childhood meningitis, brain maturation and the risk of psychosis. Eur Arch Psychiatry Clin Neurosci (2004) 0.82

CNS infection in childhood does not confer risk for later schizophrenia: a case-control study. Schizophr Res (2010) 0.82

Childhood meningitis increases the risk for adult schizophrenia. World J Biol Psychiatry (2005) 0.81

Coxsackie B 5 outbreak in a newborn nursery with 17 cases of serous meningitis. Scand J Infect Dis (1970) 0.79

Is there a viral or immune dysfunction etiology to schizophrenia? Re-evaluation a decade later. Schizophr Res (1996) 0.79

Chronic mumps virus encephalitis. Mumps antibody levels in cerebrospinal fluid. J Neuroimmunol (1985) 0.77

Articles by these authors

Cannabis use and risk of psychotic or affective mental health outcomes: a systematic review. Lancet (2007) 11.27

A mega-analysis of genome-wide association studies for major depressive disorder. Mol Psychiatry (2012) 6.34

Cognitive behavioural therapy as an adjunct to pharmacotherapy for primary care based patients with treatment resistant depression: results of the CoBalT randomised controlled trial. Lancet (2012) 5.61

Facilitated physical activity as a treatment for depressed adults: randomised controlled trial. BMJ (2012) 5.61

Oligodendrocyte dysfunction in schizophrenia and bipolar disorder. Lancet (2003) 4.84

Obstetric complications and schizophrenia: historical and meta-analytic review. Am J Psychiatry (2002) 4.03

Therapist-delivered Internet psychotherapy for depression in primary care: a randomised controlled trial. Lancet (2009) 3.90

Why psychiatry can't afford to be neurophobic. Br J Psychiatry (2009) 3.80

Gene X environment interactions at the serotonin transporter locus. Biol Psychiatry (2008) 3.80

Randomised controlled trials investigating pharmacological and psychological interventions for treatment-refractory depression. Systematic review. Br J Psychiatry (2002) 3.72

Heterogeneity in incidence rates of schizophrenia and other psychotic syndromes: findings from the 3-center AeSOP study. Arch Gen Psychiatry (2006) 3.35

Treatment of postnatal depression in low-income mothers in primary-care clinics in Santiago, Chile: a randomised controlled trial. Lancet (2007) 3.03

Incidence of schizophrenia and other psychoses in ethnic minority groups: results from the MRC AESOP Study. Psychol Med (2006) 2.79

Self reported cannabis use as a risk factor for schizophrenia in Swedish conscripts of 1969: historical cohort study. BMJ (2002) 2.74

Randomized controlled trial of effect of prescription of clozapine versus other second-generation antipsychotic drugs in resistant schizophrenia. Schizophr Bull (2006) 2.71

Early detection and intervention evaluation for people at risk of psychosis: multisite randomised controlled trial. BMJ (2012) 2.70

A longitudinal study of premorbid IQ Score and risk of developing schizophrenia, bipolar disorder, severe depression, and other nonaffective psychoses. Arch Gen Psychiatry (2004) 2.65

Resuscitation at birth and cognition at 8 years of age: a cohort study. Lancet (2009) 2.57

Outcomes of conduct problems in adolescence: 40 year follow-up of national cohort. BMJ (2009) 2.47

Violence against women by their intimate partner during pregnancy and postnatal depression: a prospective cohort study. Lancet (2010) 2.46

Detection of depression and anxiety in primary care: follow up study. BMJ (2002) 2.44

Extrapyramidal motor side-effects of first- and second-generation antipsychotic drugs. Br J Psychiatry (2012) 2.41

Deviance in fetal growth and risk of autism spectrum disorder. Am J Psychiatry (2013) 2.36

Paternal age and risk for schizophrenia. Br J Psychiatry (2003) 2.34

Disease-relevant autoantibodies in first episode schizophrenia. J Neurol (2010) 2.33

Incidence of schizophrenia and other psychoses in England, 1950-2009: a systematic review and meta-analyses. PLoS One (2012) 2.33

A qualitative study exploring how GPs decide to prescribe antidepressants. Br J Gen Pract (2005) 2.31

Paternal age and schizophrenia: a population based cohort study. BMJ (2004) 2.27

Examining interactions between risk factors for psychosis. Br J Psychiatry (2010) 2.25

If cannabis caused schizophrenia--how many cannabis users may need to be prevented in order to prevent one case of schizophrenia? England and Wales calculations. Addiction (2009) 2.25

Cannabis and schizophrenia: model projections of the impact of the rise in cannabis use on historical and future trends in schizophrenia in England and Wales. Addiction (2007) 2.20

Psychotic experiences and psychotic disorders at age 18 in relation to psychotic experiences at age 12 in a longitudinal population-based cohort study. Am J Psychiatry (2013) 2.17

Schizophrenia in the offspring of antenatally depressed mothers in the northern Finland 1966 birth cohort: relationship to family history of psychosis. Am J Psychiatry (2009) 2.11

Fetal growth and childhood behavioral problems: results from the ALSPAC cohort. Am J Epidemiol (2006) 2.09

A quantitative meta-analysis of population-based studies of premorbid intelligence and schizophrenia. Schizophr Res (2011) 2.09

Migration and autism spectrum disorder: population-based study. Br J Psychiatry (2012) 2.07

Cross-national clinical and functional remission rates: Worldwide Schizophrenia Outpatient Health Outcomes (W-SOHO) study. Br J Psychiatry (2011) 2.06

Classroom based cognitive behavioural therapy in reducing symptoms of depression in high risk adolescents: pragmatic cluster randomised controlled trial. BMJ (2012) 2.05

Raised incidence rates of all psychoses among migrant groups: findings from the East London first episode psychosis study. Arch Gen Psychiatry (2008) 1.96

Violence and psychiatric morbidity in a national household population--a report from the British Household Survey. Am J Epidemiol (2006) 1.94

Reliability and comparability of psychosis patients' retrospective reports of childhood abuse. Schizophr Bull (2009) 1.94

Obsessive-compulsive disorder: prevalence, comorbidity, impact, and help-seeking in the British National Psychiatric Morbidity Survey of 2000. Am J Psychiatry (2006) 1.93

Self-help books for depression: how can practitioners and patients make the right choice? Br J Gen Pract (2005) 1.91

Stigma revisited, disclosure of emotional problems in primary care consultations in Wales. Soc Sci Med (2003) 1.84

Prospective study of peer victimization in childhood and psychotic symptoms in a nonclinical population at age 12 years. Arch Gen Psychiatry (2009) 1.81

The patient-doctor relationship: a synthesis of the qualitative literature on patients' perspectives. Br J Gen Pract (2009) 1.80

Increased pituitary volume in antipsychotic-free and antipsychotic-treated patients of the AEsop first-onset psychosis study. Neuropsychopharmacology (2005) 1.76

Family history of schizophrenia and bipolar disorder as risk factors for autism. Arch Gen Psychiatry (2012) 1.76

Contribution of common genetic variants to antidepressant response. Biol Psychiatry (2012) 1.73

Psychosis, victimisation and childhood disadvantage: evidence from the second British National Survey of Psychiatric Morbidity. Br J Psychiatry (2004) 1.72

Maternal antibodies to dietary antigens and risk for nonaffective psychosis in offspring. Am J Psychiatry (2012) 1.72

Self-harm in first-episode psychosis. Br J Psychiatry (2008) 1.72

Substance use in a population-based clinic sample of people with first-episode psychosis. Br J Psychiatry (2007) 1.71

Infant developmental milestones and subsequent cognitive function. Ann Neurol (2007) 1.69

Negative self-schemas and the onset of depression in women: longitudinal study. Br J Psychiatry (2005) 1.69

Developmental typology of trajectories to nighttime bladder control: epidemiologic application of longitudinal latent class analysis. Am J Epidemiol (2003) 1.65

Parental socioeconomic status and risk of offspring autism spectrum disorders in a Swedish population-based study. J Am Acad Child Adolesc Psychiatry (2012) 1.65

IQ and non-clinical psychotic symptoms in 12-year-olds: results from the ALSPAC birth cohort. Br J Psychiatry (2008) 1.64

Alcohol consumption as a risk factor for anxiety and depression: results from the longitudinal follow-up of the National Psychiatric Morbidity Survey. Br J Psychiatry (2005) 1.63

Adolescent alcohol and tobacco use and early socioeconomic position: the ALSPAC birth cohort. Pediatrics (2011) 1.60

Clinical effectiveness of collaborative care for depression in UK primary care (CADET): cluster randomised controlled trial. BMJ (2013) 1.56

Childhood conduct disorder trajectories, prior risk factors and cannabis use at age 16: birth cohort study. Addiction (2013) 1.56

The association between early autistic traits and psychotic experiences in adolescence. Schizophr Res (2012) 1.55

Epilepsy and psychiatric comorbidity: a nationally representative population-based study. Epilepsia (2012) 1.54

Childhood cognitive ability and adult mental health in the British 1946 birth cohort. Soc Sci Med (2007) 1.54

Starting dose is a risk factor for allopurinol hypersensitivity syndrome: a proposed safe starting dose of allopurinol. Arthritis Rheum (2012) 1.54

Self-reported psychotic symptoms in the general population: results from the longitudinal study of the British National Psychiatric Morbidity Survey. Br J Psychiatry (2006) 1.54

Forty-year psychiatric outcomes following assessment for internalizing disorder in adolescence. Am J Psychiatry (2007) 1.54

Effects of cannabis use on outcomes of psychotic disorders: systematic review. Br J Psychiatry (2008) 1.53

Maternal depression during pregnancy and the postnatal period: risks and possible mechanisms for offspring depression at age 18 years. JAMA Psychiatry (2013) 1.52

Autism spectrum disorders in the Stockholm Youth Cohort: design, prevalence and validity. PLoS One (2012) 1.51

Association between erythrocyte sedimentation rate and IQ in Swedish males aged 18-20. Brain Behav Immun (2010) 1.49

Socio-economic position and common mental disorders. Longitudinal study in the general population in the UK. Br J Psychiatry (2006) 1.48

Ethnic differences in prisoners. 1: criminality and psychiatric morbidity. Br J Psychiatry (2002) 1.48

A longitudinal typology of symptoms of depression and anxiety over the life course. Biol Psychiatry (2007) 1.47

Cost-effectiveness of cognitive-behavioural therapy as an adjunct to pharmacotherapy for treatment-resistant depression in primary care: economic evaluation of the CoBalT Trial. Br J Psychiatry (2013) 1.44

Risk of schizophrenia and other non-affective psychosis among individuals exposed to head injury: case control study. Schizophr Res (2006) 1.43

Parental depression, maternal antidepressant use during pregnancy, and risk of autism spectrum disorders: population based case-control study. BMJ (2013) 1.43

Gender differences in incidence and age at onset of mania and bipolar disorder over a 35-year period in Camberwell, England. Am J Psychiatry (2005) 1.42

Cannabis use and outcome of recent onset psychosis. Eur Psychiatry (2005) 1.42

Recovery from schizophrenic psychoses within the northern Finland 1966 Birth Cohort. J Clin Psychiatry (2005) 1.42

Psychosis in the community and in prisons: a report from the British National Survey of psychiatric morbidity. Am J Psychiatry (2005) 1.39

Neighbourhood-level effects on psychoses: re-examining the role of context. Psychol Med (2007) 1.38

Cohort profile: risk patterns and processes for psychopathology emerging during adolescence: the ROOTS project. Int J Epidemiol (2009) 1.37

Investigating the association between cigarette smoking and schizophrenia in a cohort study. Am J Psychiatry (2003) 1.35

The structural brain correlates of neurological soft signs in AESOP first-episode psychoses study. Brain (2003) 1.35

Social adversity in childhood and the risk of developing psychosis: a national cohort study. Am J Psychiatry (2005) 1.33

Trends in service use and treatment for mental disorders in adults throughout Great Britain. Br J Psychiatry (2004) 1.32